FDA approves digital contraceptives

The German company has presented an application that can be used as the first digital contraceptive in the United States. The developers note that it is several times simpler than its counterparts.

Clue, a pioneer in femtech, is preparing to launch a digital contraceptive that will offer users a statistical forecast of ovulation as a tool for monitoring possible pregnancy. In the US, the launch of the Clue Birth Control app is scheduled for 2021, the team has yet to reveal the exact date.

The Berlin-based company also announced that they had received permission to launch from the US authorities. The plans are to launch in Europe, but the company has not yet received the necessary permits.

The application will be useful so that users will not have to track other changes in their body. The method is based on the fact that women regularly enter only one type of data: the date of the onset of menstruation. The developers note that this is a major step up in the ease of use compared to the competition of the application.

Clue’s algorithmic prediction is based on Bayesian modeling – the application displays a high-risk window for several days of the user cycle, during which unprotected intercourse can lead to pregnancy. It also displays a low-risk user window.

If you have found a spelling error, please, notify us by selecting that text and pressing Ctrl+Enter.

Alexandr Ivanov earned his Licentiate Engineer in Systems and Computer Engineering from the Free International University of Moldova. Since 2013, Alexandr has been working as a freelance web programmer.
Function: Web Developer and Editor
Alexandr Ivanov

Spelling error report

The following text will be sent to our editors: